EN 17111:2018 Virucidal Carrier Test for Medical Instrument Disinfectants

Hassle-free testing experience

Need to get a product tested? No worries! To and fro logistics are on us; we collect your products, test them and, deliver them back to you.

Summary

EN 17111:2018 is a quantitative carrier test used to validate virucidal claims for medical instrument disinfectants under practical conditions. It simulates real-use contamination on surfaces and confirms whether your formulation achieves the required โ‰ฅ4-log viral reduction. For manufacturers, EN 17111 is a critical standard to  substantiate virucidal claims for instrument disinfectants within the European regulatory framework.

Related tests for you

Determining the biocidal activity of Automated Airborne Room Disinfection Process
Quantitative suspension test for the evaluation of virucidal activity of disinfectants used in the medical area
Evaluates the Efficacy of Hygienic Handrub Products
Quantitative suspension test for the evaluation of basic bactericidal activity of chemical disinfectants and antiseptics
Quantitative suspension test for the evaluation of basic fungicidal or basic yeasticidal activity of chemical disinfectants and antiseptics (phase 1)
Quantitative Suspension Test for the Evaluation of Bactericidal Activity of Chemical Disinfectant

Quick understanding of the test

BS EN 17111:2018 - Quantitative carrier test for the evaluation of virucidal activity for instruments used in the medical area (phase 2, step 2)

EN 17111 test is a phase 2 step 2 carrier test that evaluates the virucidal efficacy of disinfectants used on medical instruments.

Applicable to disinfectant products intended for disinfection of medical instruments in areas such as hospitals, nursing homes, dental clinics and more.

  • Test suspension of viruses with interfering substances is spread on a glass carrier and allowed to dry. 
  • The carrier with the dried inoculum is immersed in disinfectant. 
  • At the end of contact time, the carriers are transferred into a maintenance medium. Viruses are recovered from the carrier surfaces by shaking and viral titre assay is performed to determine the number of viable viral particles.

Turnaround Time

Approximately 4โ€“5 weeks.
Virucidal activity of the disinfectant is calculated by comparing the results of the treated sample with the control sample.

Passing criteria

The product must demonstrate at least a 4-log reduction in the viable viral particles to pass the test.

Do you have a product that needs testing?

Get a quote from our experts today!

What is EN 17111 Virucidal Testing?

EN 17711 is a quantitative carrier test designed to evaluate the virucidal efficacy of chemical disinfectants and antiseptics intended for disinfection of medical instruments. The test simulates real-world conditions by applying a viral suspension to a defined carrier surface, allowing it to dry, and then exposing it to the disinfectant. This Phase 2, Step 2 test employs the carrier surface to mimic contamination scenarios relevant to surgical instruments, anesthesia equipment, and other reusable medical devices requiring immersion disinfection

EN 17111 complements EN 16777, which assesses virucidal activity on non-porous surfaces without immersion or mechanical action. It also extends the principles of EN 14476  (phase 2 step 1 test) which establishes the baseline for virucidal efficacy assessment to more practical conditions. For a product to claim general virucidal activity, it must meet EN 14476 requirements with Poliovirus, Adenovirus, and murine Norovirus, and EN 16777 requirements with Adenovirus and murine Norovirus.

Scope of EN 17111:2018 Standard

The EN  17111 standard is applicable to chemical disinfectant and antiseptic products used for disinfection of medical instruments via immersion. This includes products intended for use in:

    • Hospitals and surgical centers
    • Community healthcare facilities
    • Dental clinics
    • Nursing homes and elder care centers
    • Clinics at schools and kindergartens

Viruses Required Under EN 17111

  • Modified Vaccinia virus Ankara or Vaccinia virus strain Elstree
  • Adenovirus
  • Murine Norovirus
  • Murine Parvovirus

EN 17111 Test Conditions & Requirements

ParameterPre-cleaning products (Cleaner/Disinfectant)Instrument disinfection (< 40 ยฐC)Instrument disinfection (โ‰ฅ 40 ยฐC)
Virucidal activity scopeVirucidal activity against enveloped virusesVirucidal activityVirucidal activity
Mandatory test microorganismsModified Vaccinia virus Ankara (MVA) or Vaccinia virus strain ElstreeAdenovirus and Murine norovirusMurine parvovirus
Additional microorganismsAny relevant strainAny relevant strainAny relevant strain
Test temperatureAccording to manufacturerโ€™s recommendation, but at 20 ยฐCAccording to manufacturerโ€™s recommendation, between 20 ยฐC and < 40 ยฐCAccording to manufacturerโ€™s recommendation, between โ‰ฅ 40 ยฐC and 70 ยฐC
Contact timeAccording to manufacturerโ€™s recommendation, but โ‰ค 60 minAccording to manufacturerโ€™s recommendation, but โ‰ค 60 minAccording to manufacturerโ€™s recommendation, but โ‰ค 60 min
Interfering substance โ€“ Clean conditions0.3 g/L bovine albumin solution0.3 g/L bovine albumin solution0.3 g/L bovine albumin solution
Interfering substance โ€“ Dirty conditions3.0 g/L bovine albumin solution + 3.0 mL/L washed sheep erythrocytes3.0 g/L bovine albumin solution + 3.0 mL/L washed sheep erythrocytes3.0 g/L bovine albumin solution + 3.0 mL/L washed sheep erythrocytes

EN 17111 Test Procedure

Carrier preparation & drying

Test suspension of viruses with interfering substances is spread on a glass carrier and allowed to dry. This is kept to dry out for sometime.

Exposure of contaminated dried carriers to the disinfectant 

In the next step, the carrier with the dried inoculum is immersed into disinfectant. In parallel,  a control test is run wherein the glass carrier is immersed in hard water (control sample) instead of disinfectant.

Both treated and control samples are maintained for specific contact times.

Neutralization & Viral Recovery

  • At the end of contact time, the carriers are further transferred into a maintenance medium containing glass beads. Viruses are recovered from the carrier surfaces by shaking.
  • The maintenance medium with the recovered virus is subjected to infectious viral titer assay to determine the number of viable viral particles.
  • Virucidal activity is calculated by comparing the results of the treated sample with the control sample.

EN 17111 Log Reduction Requirements

To pass the EN  17111 test, the disinfectant product must demonstrate a โ‰ฅ 4 log reduction in comparison to the control test.

EN 17111 vs Other Standards

Category

EN 17111

EN 16777

EN 14476

Purpose

Evaluates virucidal efficacy of disinfectants used for immersion of medical instruments under simulated practical conditions

Evaluates virucidal efficacy of disinfectants for non-porous surfaces in medical areas under practical conditions

Evaluates  virucidal activity in a quantitative suspension test under defined lab conditions

Test Phase

Phase 2 Step 2 (Carrier test)

Phase 2 Step 2 (Carrier test)

Phase 2 Step 1 (Suspension test)

Mandatory test organisms

Adenovirus, Murine Norovirus, Murine parvovirus, Modified Vaccinia virus Ankara 

Adenovirus and Murine Norovirus for general virucidal claims

Vaccinia virus for enveloped virus claims

Enveloped & non-enveloped viruses such as Poliovirus, Adenovirus, Murine Norovirus, Vaccinia virus

Scope of products

Disinfectants for immersion of medical instruments and devices

Disinfectants intended for non-porous surface disinfection in medical areas without mechanical action

Disinfectants, antiseptics, hand hygiene products, and textile disinfectants for medical/healthcare applications

Passing criteria (Log reduction)

โ‰ฅ 4 log reduction

โ‰ฅ 4 log reduction

โ‰ฅ 4 log reduction

Importance of EN 17111 Test

Hospital-acquired infections pose a serious risk to patient safety, and ineffective disinfection of medical instruments can be a major source of viral transmission. EN 17111 addresses this problem by evaluating the virucidal efficacy of chemical disinfectants on instruments under realistic conditions.

By simulating real-world conditions, including organic soiling, use of carrier surfaces and drying of viral suspensions, it ensures reliable disinfection of instruments. The standard establishes precise efficacy criteria guiding manufacturers in product development and optimization.

Why Choose Our Lab for EN 17111 Testing

Microbe Investigations Switzerland ensures your textile products meet the highest antiviral performance standards by deliver reliable protection. Our EN 17111 testing services provide robust, standardized antiviral efficacy data to support product compliance, strengthen regulatory acceptance, and reinforce customer confidence in your hygiene and performance claims.

Request EN 17111 Testing

To get a quote on the EN 17111 test or need any additional information regarding our testing services, contact our experts today.

Frequently Asked Questions

DR. Martinoz Scholtz

MIS Labs
1. What is EN 17111:2018 test?

Itโ€™s a quantitative carrier test for evaluating the virucidal activity of chemical disinfectants and antiseptics used to immerse medical instruments under practical conditions (Phase 2, Step 2).

2. What are the Products that can be tested with EN 17111 test?

EN 17111 test is applicable to products designed to be used for the disinfection of surgical instruments, anesthesia materials, endoscopes, etc.

3. What is the Turnaround Time for EN 17111 test?

EN 17111 test takes 4-5 weeks to complete.

4. What log reduction is required under EN 17111?

A disinfectant must achieve at least a 4 log10 (โ‰ฅ99.99%) reduction to meet the passing criteria.

5. What is the difference between EN 17111 and EN 14476?

EN 17111 is a carrier surface test simulating real-world instrument disinfection (Phase 2, Step 2), while EN 14476 is a suspension test (Phase 2, Step 1) conducted in liquid.

6. Is EN 17111 required for EU disinfectant approval?

If your product is intended for immersion disinfection of medical instruments, Phase 2 Step 2 data is typically expected to support virucidal claims in Europe.

7. What viruses are tested in EN 17111?

Adenovirus, Murine norovirus, modified Vaccinia virus Ankara (and/or vaccinia Elstree), and Murine parvovirus.

8. What does Phase 2 Step 2 mean?

It refers to a European standard testing stage where products are evaluated under realistic practical conditions (e.g, dried virus on carriers) for efficacy, beyond basic suspension tests (Phase 2 Step 1).

Meet the best of the blend of
R&D, Efficacy Testing,
Innovation and Passionate
Experts at MIS.

Send us your sample and experience High quality Swiss standards, Industry leading turnaround times, and affordable prices.

    Explore More